<DOC>
	<DOCNO>NCT00190437</DOCNO>
	<brief_summary>Intensive Care Unit ( ICU ) admission acute exacerbation chronic obstructive lung disease ( COLD ) major cause morbidity mortality patient . Although bacterial mortality patient . Although bacterial viral infection consider major precipitate factor , antibiotic strategy set unclear . The absence overt infection remain controversial , adequately study patient admitted ICU . To assess benefit ( lack thereof ) routine early systemic antibiotic therapy patient COLD admit ICU . The primary objective essay evaluate effectiveness precocious antibiotic therapy length respiratory symptom admit patient polyvalent medical intensive care chronic obstructive lung disease ( COLD )</brief_summary>
	<brief_title>ANTEAB : Study Early Antibiotherapy ICU Management Acute Exacerbations COPD</brief_title>
	<detailed_description>This multicenter , randomise , double-blind control trial , compare amoxicillin-clavulanic acid administer 7 day placebo .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Patients include document suspected COLD , exclusive bronchial lung disease , admit acute exacerbation , absence overt sepsis bronchopneumonia , organ . Patients recently hospitalise , receive antibiotic since 24h , longterm steroid include</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Chronic Obstructive Lung Disease ( COLD )</keyword>
	<keyword>Randomized Clinical Trial</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Acute Exacerbation</keyword>
	<keyword>Mechanical</keyword>
	<keyword>Ventilation</keyword>
	<keyword>Intensive Care</keyword>
	<keyword>Length Stay</keyword>
	<keyword>Mortality</keyword>
</DOC>